Skip to main navigation Skip to search Skip to main content

Author Correction: Targeted pharmacological therapy restores β-cell function for diabetes remission (Nature Metabolism, (2020), 2, 2, (192-209), 10.1038/s42255-020-0171-3)

  • Stephan Sachs
  • , Aimée Bastidas-Ponce
  • , Sophie Tritschler
  • , Mostafa Bakhti
  • , Anika Böttcher
  • , Miguel A. Sánchez-Garrido
  • , Marta Tarquis-Medina
  • , Maximilian Kleinert
  • , Katrin Fischer
  • , Sigrid Jall
  • , Alexandra Harger
  • , Erik Bader
  • , Sara Roscioni
  • , Siegfried Ussar
  • , Annette Feuchtinger
  • , Burcak Yesildag
  • , Aparna Neelakandhan
  • , Christine B. Jensen
  • , Marion Cornu
  • , Bin Yang
  • Brian Finan, Richard D. DiMarchi, Matthias H. Tschöp, Fabian J. Theis, Susanna M. Hofmann, Timo D. Müller, Heiko Lickert
  • Helmholtz Zentrum München German Research Center for Environmental Health
  • Technical University of Munich
  • German Centre for Diabetes Research (DZD)
  • University of Copenhagen
  • InSphero AG
  • Novo Nordisk A/S
  • Novo Nordisk Research Center
  • Indiana University Bloomington
  • Ludwig-Maximilians-Universität München
  • Universitätsklinikum Tübingen

Research output: Contribution to journalComment/debate

3 Scopus citations

Abstract

In the version of this article initially published, in Fig. 7c, in the ‘Day 25’ panels, the ‘GLP-1–oestrogen’ image mistakenly duplicated the ‘PEG–insulin’ image. The error has been corrected in the HTML and PDF versions of the article.

Original languageEnglish
Pages (from-to)380
Number of pages1
JournalNature Metabolism
Volume2
Issue number4
DOIs
StatePublished - 1 Apr 2020

Fingerprint

Dive into the research topics of 'Author Correction: Targeted pharmacological therapy restores β-cell function for diabetes remission (Nature Metabolism, (2020), 2, 2, (192-209), 10.1038/s42255-020-0171-3)'. Together they form a unique fingerprint.

Cite this